Nov 7 (Reuters) - Johnson & Johnson (NYSE:JNJ) Vision:
* JOHNSON & JOHNSON VISION ANNOUNCES HEALTH CANADA HAS ISSUED A MEDICAL DEVICE LICENSE FOR FIRST-OF-ITS-KIND CONTACT LENS ACUVUE OASYS WITH TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY
* TWO-WEEK REUSABLE CONTACT LENS WILL BE COMMERCIALLY AVAILABLE IN FIRST HALF OF 2019.